MARKET

IMRN

IMRN

Immuron Ltd
NASDAQ
1.880
-0.029
-1.53%
After Hours: 1.750 -0.13 -6.91% 16:09 11/22 EST
OPEN
1.860
PREV CLOSE
1.909
HIGH
1.910
LOW
1.800
VOLUME
4.56K
TURNOVER
--
52 WEEK HIGH
5.96
52 WEEK LOW
1.590
MARKET CAP
10.72M
P/E (TTM)
-2.3151
1D
5D
1M
3M
1Y
5Y
1D
Immuron CEO, Steven Lydeamore presentation to 21st Virtual Investor Summit Microcap Event
Barchart · 1d ago
Weekly Report: what happened at IMRN last week (1111-1115)?
Weekly Report · 5d ago
Weekly Report: what happened at IMRN last week (1104-1108)?
Weekly Report · 11/11 12:02
Weekly Report: what happened at IMRN last week (1028-1101)?
Weekly Report · 11/04 11:58
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 10/29 12:08
Why VF Corp Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket
Benzinga · 10/29 10:12
Weekly Report: what happened at IMRN last week (1021-1025)?
Weekly Report · 10/28 11:48
Weekly Report: what happened at IMRN last week (1014-1018)?
Weekly Report · 10/21 11:44
More
About IMRN
Immuron Limited is an Australia-based biopharmaceutical company focused on developing and commercializing orally delivered targeted polyclonal antibodies for the treatment of infectious diseases. It operates through two segments: Research and development (R&D), and Hyperimmune products. The R&D segment is focused on R&D projects performed in Australia and the United States. Hyperimmune products segment is engaged in Travelan and Protectyn activities which occur predominantly in Australia, the United States and Canada. Its flagship products consist of Travelan and Protectyn. Travelan is an orally administered passive immunotherapy that prophylactically reduces the likelihood of contracting traveler’s diarrhea and is sold in pharmacies throughout Australia. Protectyn is sold online and in health practitioner clinics and is marketed as an immune supplement to help maintain a healthy digestive function and liver. Its clinical programs include Travelan (IMM-124E), IMM-529, and CampETEC.

Webull offers Immuron Ltd - ADR stock information, including NASDAQ: IMRN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IMRN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IMRN stock methods without spending real money on the virtual paper trading platform.